SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose Passive 0.9% Stake in AnaptysBio Inc.
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.9% in AnaptysBio Inc. as of May 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership of common stock in ANAPTYSBIO INC.
- As of May 30, 2025, the aggregate amount beneficially owned by FMR LLC and Abigail P. Johnson is 254,211.72 shares.
- This represents 0.9% of the class of ANAPTYSBIO INC's common stock.
- FMR LLC holds sole voting power over 253,287.00 shares and sole dispositive power over 254,211.72 shares.
- Abigail P. Johnson holds sole dispositive power over 254,211.72 shares, with no sole or shared voting power directly.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- FMR LLC is classified as a parent holding company or control person, and Abigail P. Johnson is an individual.
- Several FMR LLC subsidiaries are listed as entities that beneficially own shares, including FIAM LLC (Investment Adviser), Fidelity Institutional Asset Management Trust Company (Bank), Fidelity Management & Research Company LLC (Investment Adviser), and Strategic Advisers LLC (Investment Adviser).
- Members of the Johnson family, including Abigail P. Johnson, are the predominant owners of FMR LLC's Series B voting common shares, representing 49% of the voting power, and have a voting agreement to vote in accordance with the majority.
Sentiment
Score: 5
Explanation: This is a neutral, factual filing about passive ownership and does not convey positive or negative sentiment regarding the issuer's performance or prospects.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of passive institutional ownership and does not provide specific insights into broader industry trends or competitive landscape for AnaptysBio Inc. It reflects a standard investment position by a large asset manager.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure Disclosure | The filing details the ownership structure of FMR LLC, noting that members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares (49% voting power) and have a shareholders' voting agreement to vote in accordance with the majority. This clarifies the control structure of the reporting entity, FMR LLC, rather than AnaptysBio Inc. | NA | This clarifies the control structure of the reporting entity (FMR LLC) and its subsidiaries, which are the beneficial owners, but does not indicate any direct changes or impacts on AnaptysBio Inc.'s corporate governance. |
Stakeholder Impact
- Minimal direct impact on shareholders, employees, customers, suppliers, or creditors of AnaptysBio Inc. as this is a passive ownership disclosure below the 5% threshold, indicating no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number: -23-000003) was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney (accession number: -23-000038) was incorporated by reference. |
| 2025-05-30 | Date of event which requires filing of this statement (measurement date for beneficial ownership). |
| 2025-06-05 | Date of filing of this Schedule 13G Amendment No. 2. |
Keywords
ANAPTYSBIO INC, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, passive investment, SEC filing, institutional ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.